Sequent Scientific completes transaction for consolidating shareholding in Fendigo BV

The transaction was for acquisition of 15% stake from Servatius Justinus Cornelius Maria Van Der Heijden in Fendigo BV through Alivira Animal Health Limited, Ireland.

Oct 09, 2020 04:10 IST India Infoline News Service

Sequent Scientific
Sequent Scientific Limited has completed transaction on proposed acquisition of 15% stake from Servatius Justinus Cornelius Maria Van Der Heijden in Fendigo BV through Alivira Animal Health Limited, Ireland, Wholly Owned Subsidiary of the company.

“On completion of the said transaction, Fendigo BV has become a Wholly Owned Subsidiary of the company,” company informed the exchanges on Friday.

Sequent Scientific ended at Rs155.40, down by Rs3 or 1.89% from its previous closing of Rs158.40 on the BSE.
The scrip opened at Rs161.75 and has touched a high and low of Rs162.70 and Rs154.50 respectively.

Related Story